Pfizer’s antiviral pills called Paxlovid reduced the risk of getting hospitalized, dying or developing 10 long-term health conditions in the six months after a COVID-19 infection.
from COVID ). To assess the drug’s longer-term effects, Al-Aly and colleagues examined medical records from the U.S. Department of Veterans Affairs’ health care system. The researchers found more than 280,000 patients who had a positive COVID test in 2022 and at least one risk factor for developing severe illness. Of those people, nearly 36,000 got Paxlovid within five days of their positive test result.
Some researchers dispute whether the study fully captures what long COVID is. The condition is notoriously For instance, many people with long COVID experience post-exertional malaise, or extreme tiredness after exercise, says Monica Verduzco-Gutierrez, director of the post-COVID recovery clinic at the University of Texas Health Science Center at San Antonio. But there isn’t a medical code for that condition, she says, “so it’s hard to pull out of a medical record review.”
France Dernières Nouvelles, France Actualités
Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.
Oura study shows covid-19 can impact your biometrics for weeks after infectionJust in time for the next pandemic.
Lire la suite »
Wearing a fitness tracker could help you detect COVID faster | Digital TrendsResearch into COVID19 by Oura shows the OuraRing smart ring's sensors collect data that can warn when you're getting sick.
Lire la suite »
COVID-origins report sparks debate over major genome hub GISAIDGISAID revoked researchers’ access following the report, sparking discussion about findings based on data found in online repositories.
Lire la suite »
Manx Long Covid and chronic fatigue services promotedManx Care encourages Long Covid patients to find out more about the range of support available.
Lire la suite »
Long COVID remains an uphill battle for many Americans: 'Every day, getting up is a fight'Although COVID-19 cases and hospitalizations have decreased, long COVID remains a constant presence in the lives of many Americans.
Lire la suite »
COVID-19 RNA Hijacking Uncovered: Unlocking the Door to Innovative TreatmentsCoronavirus disease (COVID-19) hijacks parts of infected cells' vital RNA machinery, thereby blocking important functions in the cells. These damaging changes in the RNA can likely be reversed, potentially leading to new drugs against COVID-19, University of Gothenburg researchers show. Genetic m
Lire la suite »